ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc (0LC7)

11.96
0.00
( 0.00% )
Updated: 19:00:00

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 317k1.1M2.05M1.98M15.09M23.49M14.88M9.94M
Operating Income -47.96M-54.69M-64.3M-77.74M-82.3M-99.42M-135.87M-128.99M
Pre Tax Income -47.74M-54.01M-62.28M-75.44M-84.04M-86.56M-94.65M-164.57M
Net Income -51.42M-54.01M-62.28M-75.44M-84.04M-86.56M-94.65M-164.57M
Preferred Dividends -3.68M0000000
Basic Earnings Per Share (EPS) -2.199-2.044-1.844-1.739-1.495-1.396-4.671-7.812
EBIT -47.74M-54.01M-62.28M-75.44M-82.3M-99.42M-135.87M-128.99M
EBITDA -46.69M-53.16M-62.69M-75.22M-79.52M-96.66M-133.17M-126.69M

Your Recent History

Delayed Upgrade Clock